D.E. Shaw & Co’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.51M Sell
274,699
-282,911
-51% -$6.95M ﹤0.01% 2258
2025
Q4
$15.9M Buy
557,610
+19,197
+4% +$520K 0.01% 1387
2025
Q3
$15.9M Sell
538,413
-1,468,178
-73% -$40.1M 0.01% 1343
2025
Q2
$57.8M Buy
2,006,591
+663,566
+49% +$19.6M 0.04% 513
2025
Q1
$47M Sell
1,343,025
-385,588
-22% -$15.7M 0.04% 506
2024
Q4
$77M Buy
1,728,613
+50,775
+3% +$2.08M 0.06% 411
2024
Q3
$76.5M Buy
1,677,838
+121,194
+8% +$4.9M 0.07% 356
2024
Q2
$51.7M Buy
1,556,644
+1,081,364
+228% +$44.2M 0.05% 448
2024
Q1
$22.8M Buy
+475,280
New +$27.7M 0.02% 847
2023
Q1
Sell
-4,300
Closed -$368K 4779
2022
Q4
$368K Sell
4,300
-11,441
-73% -$969K ﹤0.01% 4004
2022
Q3
$1.13M Sell
15,741
-26,452
-63% -$2.37M ﹤0.01% 3507
2022
Q2
$4.1M Buy
42,193
+34,693
+463% +$3.54M ﹤0.01% 2365
2022
Q1
$843K Sell
7,500
-54,700
-88% -$5.83M ﹤0.01% 4040
2021
Q4
$8.4M Buy
+62,200
New +$8.66M 0.01% 1833
2021
Q2
Sell
-3,152
Closed -$371K 4964
2021
Q1
$403K Sell
3,152
-3,486
-53% -$644K ﹤0.01% 3601
2020
Q4
$1.19M Sell
6,638
-14,620
-69% -$3.25M ﹤0.01% 2908
2020
Q3
$4.66M Buy
+21,258
New +$4.74M ﹤0.01% 1753
2020
Q2
Sell
-218,854
Closed -$21.4M 4215
2020
Q1
$21.4M Buy
218,854
+41,568
+23% +$3.36M 0.03% 589
2019
Q4
$13.3M Sell
177,286
-11,555
-6% -$746K 0.02% 1039
2019
Q3
$11.6M Sell
188,841
-73,719
-28% -$4.44M 0.01% 1085
2019
Q2
$15.6M Sell
262,560
-75,013
-22% -$4.5M 0.02% 886
2019
Q1
$22.1M Buy
337,573
+18,059
+6% +$1.09M 0.03% 680
2018
Q4
$15.6M Sell
319,514
-13,768
-4% -$822K 0.02% 825
2018
Q3
$21.7M Sell
333,282
-61,304
-16% -$4.29M 0.03% 743
2018
Q2
$26.2M Sell
394,586
-23,477
-6% -$1.42M 0.03% 593
2018
Q1
$21.7M Sell
418,063
-80,323
-16% -$3.74M 0.03% 625
2017
Q4
$21.6M Sell
498,386
-71,407
-13% -$2.92M 0.03% 646
2017
Q3
$25M Buy
569,793
+81,884
+17% +$2.85M 0.04% 526
2017
Q2
$13.2M Buy
487,909
+89,770
+23% +$2.22M 0.02% 767
2017
Q1
$9.01M Buy
398,139
+4,746
+1% +$98.1K 0.02% 941
2016
Q4
$8.43M Sell
393,393
-20,989
-5% -$450K 0.01% 1046
2016
Q3
$9.15M Sell
414,382
-18,033
-4% -$385K 0.02% 938
2016
Q2
$7.72M Buy
432,415
+21,276
+5% +$368K 0.01% 1037
2016
Q1
$7.1M Sell
411,139
-7,944
-2% -$133K 0.01% 1053
2015
Q4
$8.88M Buy
419,083
+135,847
+48% +$2.76M 0.01% 1029
2015
Q3
$5.35M Buy
283,236
+87,119
+44% +$1.86M 0.01% 1347
2015
Q2
$4.5M Buy
196,117
+76,603
+64% +$1.78M 0.01% 1550
2015
Q1
$3.22M Buy
119,514
+50,483
+73% +$1.29M ﹤0.01% 1687
2014
Q4
$2M Buy
69,031
+19,926
+41% +$540K ﹤0.01% 2289
2014
Q3
$1.32M Buy
+49,105
New +$1.17M ﹤0.01% 2582
2013
Q4
Sell
-9,705
Closed -$276K 4651
2013
Q3
$276K Sell
9,705
-5,733
-37% -$156K ﹤0.01% 3930
2013
Q2
$394K Buy
+15,438
New +$362K ﹤0.01% 3410

Other funds holding QDEL

D.E. Shaw & Co's QDEL Position: Q1 2026 in Review

D.E. Shaw & Co reduced its QuidelOrtho (QDEL) stake by 51% in Q1 2026, selling an estimated $6.95M and leaving 274,699 shares worth $4.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2258.

D.E. Shaw & Co first reported a position in QDEL in Q2 2013 and has held it in 42 quarters since. The position peaked at $77M in Q4 2024. 238 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

  • D.E. Shaw & Co held 274,699 shares of QuidelOrtho worth $4.51M as of Q1 2026.
  • D.E. Shaw & Co sold 282,911 QuidelOrtho shares in Q1 2026, an estimated $6.95M.
  • QuidelOrtho made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2258 holding.
  • D.E. Shaw & Co first reported a position in QuidelOrtho in Q2 2013 and has held it in 42 quarters since.
  • D.E. Shaw & Co's QuidelOrtho position peaked at $77M in Q4 2024.
  • 238 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.